Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06399705 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

Study acronym: RECHARGE:M
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 35 wordsv6
  2. Study sites: 14 to 18v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 14
    • Start date changed from estimate of Sep 1, 2024 to Oct 2, 2024
    • Study title expanded, about 2 words
    v4
  4. Start date: Jul 1, 2024 to Sep 1, 2024v3
  5. Start date: May 1, 2024 to Jul 1, 2024v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an open-heart operation in which healthy blood vessels from inside the chest, leg, and/or forearm are used to "bypass" the blockages (like a detour). Outcomes will be measured by comparing survival and improvement in quality-of-life.
Trial Details
NCT Number NCT06399705
Lead Sponsor Weill Medical College of Cornell University
Collaborators: Patient-Centered Outcomes Research Institute, Icahn School of Medicine at Mount Sinai
Conditions
(from sponsor)		 Coronary Artery Disease
Related terms Coronary Artery Disease
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov